Safety, Tolerability and Pharmacokinetics Study in Patients with Pulmonary Arterial Hypertension (PAH) Temporarily Switching from Oral to IV Selexipag

被引:3
|
作者
Klose, H. [1 ]
Chin, K. [2 ]
Ewert, R. [3 ]
Gall, H. [4 ]
Parambil, J. [5 ]
Poch, D. [6 ]
Seyfarth, H. [7 ]
Axelsen, L. [8 ]
Schmitz, S. Hsu [9 ]
Stein, C. [10 ]
Preston, I. [11 ]
机构
[1] Univ Med Ctr Hamburg Eppendorf, Dept Resp Med, Ctr Oncol, Hamburg, Germany
[2] Univ Texas Southwestern Med Ctr Dallas, Dallas, TX 75390 USA
[3] Ernst Moritz Arndt Univ Greifswald, Dept Resp Med, Clin Internal Med, Greifswald, Germany
[4] UGMLC, Internal Med, Giessen, Germany
[5] Cleveland Clin, Dept Pulm Allergy & Crit Care Med, Resp Inst, Cleveland, OH 44106 USA
[6] Univ Calif San Diego, Dept Pulm Crit Care, San Diego, CA 92103 USA
[7] Univ Leipzig, Dept Resp Med, Leipzig, Germany
[8] Actel Pharmaceut Ltd, Clin Pharmacol, Allschwil, Switzerland
[9] Actel Pharmaceut Ltd, Biostat, Allschwil, Switzerland
[10] Actel Pharmaceut Ltd, Clin Sci, Allschwil, Switzerland
[11] Tufts Univ, Sch Med, Tufts Med Ctr, Pulm Crit Care & Sleep Div, Boston, MA 02111 USA
来源
关键词
D O I
10.1016/j.healun.2019.01.1247
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
1237
引用
收藏
页码:S490 / S490
页数:1
相关论文
共 50 条
  • [21] Clinical Characteristics and Treatment Patterns in Patients with Pulmonary Arterial Hypertension (PAH) Initiating Selexipag in the EXPOSURE Observational Study
    Lange, T. J.
    Escribano, P.
    Biedermann, P.
    Muller, A.
    Sun, H.
    Soderberg, S.
    Gaine, S.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 201
  • [22] Transition From Oral Treprostinil to Selexipag in a Patient With Pulmonary Arterial Hypertension
    Verlinden, Nathan J.
    Walter, Claire
    Kanwar, Manreet
    Raina, Amresh
    ANNALS OF PHARMACOTHERAPY, 2019, 53 (07) : 764 - 765
  • [23] Clinical Characteristics and Treatment Patterns in Patients with Pulmonary Arterial Hypertension (PAH) Initiating Selexipag in the EXPOSURE Observational Study
    Lange, T. J.
    Escribano, P.
    Biedermann, P.
    Muller, A.
    Sun, H.
    Soderberg, S.
    Gaine, S.
    PNEUMOLOGIE, 2021, 75 : S22 - S22
  • [24] Persistence and Predictors of Persistency for Pulmonary Arterial Hypertension (PAH) Patients on Selexipag in Canada: A Retrospective Claims Database Study
    Ibrahim, E.
    Mielniczuk, L.
    Provencher, S.
    Swiston, J.
    Weatherald, J.
    Yip, C.
    Zhang, C.
    Murray, J.
    Badin, M.
    Golden, S.
    Millson, B.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2023, 207
  • [25] Survival in Pulmonary Arterial Hypertension (PAH) for 669 Patients Treated with Selexipag in Clinical Practice: Insights from EXPOSURE
    Soderberg, S.
    Subias, P. Escribano
    O'Donovan, C.
    Muller, A.
    Fontana, M.
    Lange, T. J.
    Gaine, S.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2024, 43 (04): : S85 - S85
  • [26] REAL-WORLD USE OF SELEXIPAG AND OTHER PULMONARY ARTERIAL HYPERTENSION (PAH) THERAPIES: AN OBSERVATIONAL COHORT STUDY IN PATIENTS WITH PAH (EXPOSURE)
    Muller, A.
    Soderberg, S.
    Escribano, P.
    Biedermann, P.
    Sun, H.
    Lange, T. J.
    Gaine, S.
    VALUE IN HEALTH, 2019, 22 : S602 - S603
  • [27] Safety and efficacy of transitioning from selexipag to oral treprostinil in pulmonary arterial hypertension: Findings from the ADAPT registry
    Lachant, D.
    Minkin, R.
    Swisher, J.
    Mogri, M.
    Zolty, R.
    Hwang, S.
    Seaman, S.
    Broderick, M.
    Sahay, S.
    PULMONARY PHARMACOLOGY & THERAPEUTICS, 2023, 82
  • [28] Transitioning Stable Pulmonary Arterial Hypertension Patients from Parenteral Prostacyclin Therapy to Oral Selexipag
    Hinkamp, C. A.
    Bartolome, S.
    Torres, F.
    Igenoza, O.
    Kingman, M.
    Harden, S.
    Chin, K. M.
    Shah, T. G.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 201
  • [29] Population pharmacokinetics of selexipag for dose selection and confirmation in pediatric patients with pulmonary arterial hypertension
    Axelsen, Lene Nygaard
    Kuemmel, Anne
    Ruixo, Juan Jose Perez
    Russu, Alberto
    CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY, 2024, 13 (12): : 2185 - 2195
  • [30] TRANSITIONING FROM PARENTERAL PROSTACYCLIN THERAPY TO ORAL SELEXIPAG IN PULMONARY ARTERIAL HYPERTENSION
    Budhram, Brandon
    Gardner, Andrea
    Hambly, Nathan
    CHEST, 2021, 160 (04) : 2219A - 2220A